Bayerische Motoren Werke ADR (BMWYY)

Scientists at Southampton University have created new antibodies that supercharge the immune system’s ability to identify and kill cancer cells. This approach involved clustering immune receptors in the body so that stronger signals can be sent out to the specialized cells responsible for zeroing in and killing cancer cells.

Cars for sale at TM Motors now include a significantly expanded pre-owned vehicle inventory, offering Riverside-area drivers an even wider selection of quality automobiles. Located at 10100 Arlington Ave., the dealership continues building its reputation as a go-to destination for affordable, reliable transportation options. This expansion reflects the company's commitment to meeting growing demand while maintaining the fair pricing and superior service that have defined its approach to automotive retail.

Lantern Pharma (NASDAQ: LTRN) announced that the U.S. Food and Drug Administration has granted Orphan Drug Designation to LP-284 for the treatment of soft tissue sarcomas, marking the third orphan designation for the program and the sixth overall across the company clinical pipeline. The designation expands LP-284 beyond hematologic malignancies into solid tumors and reflects its synthetic lethal mechanism targeting DNA repair deficiencies, which are common in adult soft tissue sarcomas. Lantern said the designation supports an accelerated regulatory pathway for LP-284 as it continues Phase 1 evaluation in B-cell non-Hodgkin lymphomas and advances development in additional rare cancer indications.

In today’s competitive manufacturing landscape, an injection mold is more than just a tool—it’s a strategic asset that determines your product’s time-to-market, cost efficiency, and quality consistency. The steel that forms this asset is its very foundation. For Tier-1 automotive suppliers, appliance, furniture, and logistics manufacturers worldwide, navigating complex steel grades and volatile supply chains to make the optimal material choice is a core challenge demanding both technical expertise and commercial insight.

Dubai and tourism are two things that go hand in hand since there is an indefinite number of people visiting Dubai every year. And by the look of it, this number is only going to increase in the coming years. The reason there is such a demand to visit Dubai is that there is no […]

Steve’s Imports continues to stand out as a reliable auto repair shop in Portland OR by consistently delivering high-quality workmanship paired with attentive, customer-focused service. Known for servicing a wide range of domestic and import vehicles, the shop has built its reputation by focusing on accuracy, transparency, and long-term vehicle reliability. From everyday maintenance to complex diagnostic challenges, every service is approached with the same goal: ensuring customers feel confident in both the work performed and the people performing it.

The recent vaccine policy changes that the U.S. government announced have astounded experts because the changes reduce recommended vaccines by one third and put the U.S. behinds its peer countries. This change shifts the U.S. from the position of leader on vaccination to a country that lags other developed nations on matters of disease prevention.

The normal practice after someone has undergone a surgical procedure has been to administer anti-inflammatory medications. However, new research conducted at Michigan State University (MSU) suggests that this could be counterproductive and may be the reason why some patients develop chronic pain that lasts for years after their surgery.

Cutaneous T-cell lymphoma, or CTCL, is a rare form of non-Hodgkin lymphoma that primarily affects the skin, often presenting with symptoms that closely resemble common dermatologic conditions such as eczema or psoriasis, leading to frequent misdiagnosis and delayed treatment. These diagnostic delays can allow the disease to progress silently for years, increasing patient suffering and complicating care. A late-stage biopharmaceutical company, Soligenix (NASDAQ: SNGX) is developing therapies aimed at addressing critical gaps in rare disease treatment, including CTCL.

Oragenics (NYSE American: OGEN) announced that it will present at the upcoming Sequire Investor Summit 2026, scheduled for Jan. 20–22, 2026, at the Condado Vanderbilt Hotel in San Juan, Puerto Rico. During the conference, the Company plans to highlight its novel approach to addressing the significant unmet medical need in concussion and mild traumatic brain injury, including progress toward advancing its ONP-002 clinical program into Phase 2a studies, an area where no approved drug therapies currently exist, according to Oragenics Chief Executive Officer Janet Huffman.

Oklahoma City, OK - Expert Auto Care continues to provide trusted automotive repair and maintenance services to drivers across Oklahoma City. The auto repair shop serves both domestic and European vehicles, offering solutions that prioritize long-term reliability, safety, and performance. By combining technical expertise with practical service planning, Expert Auto Care helps customers keep their vehicles in optimal condition year-round.

A new collaboration between Penn State College of Medicine and Targepeutics seeks to advance research into a promising combination therapy that offers hope to families with children diagnosed with DIPG (diffuse intrinsic pontine glioma).

Colibri Car Wrap and Detailing regularly works on vehicles driven in Toronto. The shop handles everything from basic wash and wax services to full paint correction, ceramic coating application, and interior restoration for high-end vehicles that need more than a quick run through an automated car wash. Detailing at this level means multi-step paint decontamination, clay bar treatment to remove bonded contaminants, machine polishing to eliminate swirl marks and light scratches, and protective coatings that actually last instead of washing off after three weeks.

Immunotherapy has emerged as a more gentle way to treat cancer over the past few years. However, it is very expensive and results are usually inconsistent among patients, especially those suffering from solid tumors. Researchers in Hong Kong have come up with a biomaterial containing silica that can help to address the current shortcomings of immunotherapy and dramatically improve efficacy rates.

At least 40 million individuals from around the world use ChatGPT each day seeking information on health care-related topics, an analysis conducted by AI tool Knit. The report underscores how people use the technology and the need for oversight so that millions don’t get wrong information on such an important matter as their health.

Estrella Immunopharma (NASDAQ: ESLA, ESLAW) announced the closing of its previously announced registered direct offering with a single healthcare-focused institutional investor, generating aggregate gross proceeds of approximately $8.0 million. The offering included the issuance of 4,063,290 shares of common stock and 1,000,000 pre-funded warrants, together with a concurrent private placement of common warrants to purchase up to 7,594,935 additional shares, with net proceeds expected to be used for general corporate purposes and working capital as the company advances its CD19 and CD22-targeted ARTEMIS T-cell therapy programs, including lead candidate EB103. Aegis Capital Corp. acted as exclusive placement agent for the offerings.

Scinai Immunotherapeutics (NASDAQ: SCNI) announced that Chief Executive Officer Amir Reichman will co-lead a Manufacturers Association of Israel–organized roundtable discussion titled “Biopharma Manufacturing in Israel: Capabilities, Gaps, and Scale” during HealthIL Week 2026. The session, scheduled for Jan. 19, 2026, at Expo Tel Aviv, will focus on Israel’s biopharma development and manufacturing ecosystem, including early-stage development, CMC activities, and clinical manufacturing, as well as readiness for later-stage and commercial manufacturing. The roundtable is expected to bring together representatives from government agencies, biopharma manufacturers, CDMOs, multinational pharmaceutical companies, biotech firms, and investors to examine current capabilities, structural gaps, and collaboration models shaping the sector’s future.

TransCode Therapeutics (NASDAQ: RNAZ) announced the publication of peer-reviewed preclinical research supporting the use of its lead candidate, TTX-MC138, for the treatment of glioblastoma multiforme, one of the most aggressive forms of brain cancer. The study, conducted in collaboration with Michigan State University and published in the Journal of Functional Biomaterials, demonstrated that systemic delivery of TTX-MC138 successfully reached brain tumors in orthotopic glioblastoma models, significantly increased tumor cell apoptosis, and resulted in a statistically significant improvement in survival. The findings further validate TransCode’s TTX delivery platform and support the potential advancement of TTX-MC138 into future clinical evaluation for patients with glioblastoma, building on completed IND-enabling studies and existing Phase 1 clinical experience outside the central nervous system.

The World Health Organization (WHO), the agency of the United Nations responsible for overseeing matters related to global health, revealed that 2025 was marked by notable progress in ensuring populations around the world were supported to have good health. However, climate shocks, conflicts and funding cuts strained many health systems around the world and put a damper on the prospects for sustained improvements to health in the years to come.

BMW collision repair in West LA – OEM-first repairs, BMW factory-trained technicians, and exceptional customer service from a family-owned shop serving Santa Monica and the Westside since 1972.

Used trucks Riverside buyers have been searching for are now more accessible than ever as TM Motors expands its inventory of quality pre-owned vehicles. The dealership, located at 10100 Arlington Ave., continues to build its reputation for transparent pricing and customer-focused service in the competitive automotive market, offering Riverside-area buyers an enhanced selection of reliable transportation options.

December 10, the EXLANTIX ET received the highest five-star safety rating in the latest Euro NCAP (2024 protocol) assessment.

The young population faces an increasing health challenge posed by brain tumors affecting adolescents and children. While their occurrence isn’t as common as that of other cancers in this demographic group, brain cancers account for the biggest fraction of fatalities related to cancer in this group. Many questions have therefore emerged regarding whether modern screens and lifestyles play a role in the rise of brain cancer among younger people.

United States, December 25, 2025 -- As part of the UK 2026 Budget announcement, a new pay-per-mile electric vehicle tax has been introduced, set to come into effect starting in 2028. This tax represents a major shift in how electric vehicle (EV) ownership will be taxed, directly affecting many EV owners, including drivers of popular models such as the Porsche Taycan, BMW i4 with curved display, various Toyota and Lexus electric vehicles and many more. Carcode, a leading provider of mileage protection services, is calling attention to the implications of this change and offering solutions to help EV owners navigate the shifting landscape.

CarGym, a leader in high-performance aftermarket parts for European luxury vehicles, has expanded its global presence. This move strengthens the company's footprint in international markets, offering premium parts for luxury cars worldwide.